Hyperkalemia-induced residual neuromuscular blockade: A case report

AANA Journal

Volumn 73, Issue 6, 2005, Pages 437-441

  Wilbanks, Bryan A ^a,b   Wakim, Judith ^a,c   Daicoff, Barbara ^a,c   Monterde, Scott ^a,d  

^a Huntsville Hospital ^*

^b HUNTSVILLE HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

^d Anesthesiology Consultants Exchange   (United States)

Author keywords

Electrolytes; Hyperkalemia; Postoperative complications; Residual neuromuscular blockade

Indexed keywords

ATROPINE; DOPAMINE; EDROPHONIUM; ETOMIDATE; FENTANYL; ISOFLURANE; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PHENYLEPHRINE; POLYSTYRENESULFONATE SODIUM; POTASSIUM; POTASSIUM ION; SODIUM CHLORIDE; VECURONIUM;

AGED; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HIP FRACTURE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOTENSION; LUNG CONGESTION; MEMBRANE DEPOLARIZATION; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; POSTOPERATIVE COMPLICATION; POTASSIUM BLOOD LEVEL; THORAX RADIOGRAPHY;

EID: 28844446607     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Morgan GE, Mikhail MS. Clinical Anesthesiology. 3rd ed. Stamford, Conn: Appleton & Lange; 2001:798-800.
2. Bready LL, Hamilton KR. Prolonged postoperative apnea. In: Bready LL, Mullins RM, Noorily SH, Smith RB, eds. Decision Making in Anesthesiology: An Algorithmic Approach. 3rd ed. St Louis: Mosby, Inc; 2000:606-607.
3. Kopman AF, Kumar S, Klewicka MM, Neuman GG. The staircase phenomenon: implications for monitoring of neuromuscular transmission. Anesthesiology. 2001;95:403-407.
4. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology. 2003;98:1037-1039.
5. Stoelting RK, Dierdorf SF. Anesthesia and Co-existing Disease. 4th ed. New York, NY: Churchill Livingstone; 2002:373-394.
6. Hirsch I. Hyperkalemia. In: Roizen MF, Fleischer LA. Essence of Anesthesia Practice. Philadelphia, Pa: WB Saunders Company; 1997:170.
7. Stoelting RK. Pharmacology and Physiology in Anesthetic Practice. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:547-548.
8. Stein J. Internal Medicine. 5th ed. St Louis, Mo: Mosby, 1998:831-832.
9. Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium replacement in clinical practice: a contemporary review by the Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160:2429-2436.
10. Guyton AC, Hall JE. Textbook of Medical Physiology. 10th ed. Philadelphia, Pa: WB Saunders Company; 2000:336-339.
11. Webster A, Brady W, Morris F. Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration. Emerg Med J. 2002;19:74-77.
12. Davey M, Caldicott D. Calcium salts in management of hyperkalaemia [letter]. Emerg Med J. 2001;18:233.
13. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med. 1998;158:917-924.
14. McMorran S. Treatment of hyperkalaemia in the emergency department [letter]. Emerg Med J. 2001;18:233.